Navigation Links
New lease of life for asthmatics by Accentia Biopharmaceuticals

Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), through its specialty pharmaceuticals subsidiary, TEAMM Pharmaceuticals, Inc., has developed MD Turbo.// It is the first and only available product that transforms many of the most commonly prescribed metered dose inhalers (MDIs) into breath-activated, dose-counting inhalers. MD Turbo will be available at pharmacies in May of this year.

Gary Cantrell, TEAMM Executive Vice President of Sales and Marketing said, "MDIs are most often used as rescue medications during acute attacks. Improper dosing and other misuses can lead to negative outcomes, such as the exacerbation of symptoms and even hospitalization. But with MD Turbo physicians will be able to prescribe their drug of choice in combination with an easy to use, handheld, breath-activated device to overcome the delivery challenges often facing their patients."

"MDIs have been around for about 50 years. But MD Turbo is the first companion product to solve two of the biggest challenges facing MDI users: coordination of inhaler actuation with patient's breath, and the accounting of how much medication is left in the inhaler. We are all very excited about introducing a new product to the market that can improve the quality of care," said an excited Gil Mott, President and Chief Executive Officer of Respirics Inc.

More than 40 million MDIs are prescribed each year in the United States alone.

So it would be a lease of fresh air for many asthma patients.


'"/>




Page: 1

Related medicine news :

1. Want skin cancer? Please have a cigarette
2. Sweet corn releases antioxidants on cooking
3. Pause as you please
4. Stents That Release Medication To Check Artery Narrowing
5. NABH Health accreditations final draft to be released by this month
6. Chicago: Dad, I need you desperately, Please come back
7. Students Seek Help From Prisoners for Kidnapped Childs Release
8. Indian National in Saudi Jail will be released soon
9. 10-year-old Pleads, Herceptin For My Mum, Please
10. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
11. An International Growth Standard For Childs Releases By WHO
Post Your Comments:
(Date:7/9/2008)...sts.com, a leader in online insurance data and fre...rehensive information to help voters understand th...ealth reform as election 2008 nears. The site, whi...al on medical, auto, homeowners, and life insuranc... in coverage for themselves and their families. ,...
(Date:7/8/2008)...through adolescence may experience unhealthy level... always clear. In fact, many potential causes of ...on to be published in The Journal of Pediatrics ...alcohol and coffee consumption on weight gain in a...lleagues from Harvard Medical School, Brigham & Wo...
(Date:7/8/2008)...ly to develop disease , , TUESDAY, July...els of iron in men with peripheral arterial diseas...cording to a new study. , Lower levels of iron ...wer cancer incidence in observational studies. ,...d trial of men with peripheral arterial disease le...
(Date:7/8/2008)...Delays in Oxygen Orders, Lack of,Trained Technicia.../ -- The new Medicare,competitive bidding program ...and chaos for beneficiaries, physicians, hospital ...oviders across the country since it,was implemente...g program has triggered widespread disruptions in ...
Breaking Medicine News(10 mins):Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3Health News:The Internet, alcohol and sleep 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5
...aper on chronic obstructive pulmonary disease (COP...re often useful for patients of this disease to ha...c obstructive pulmonary disease (COPD) are lung di...d conditions like lung tissue destruction, airway ...
...e recent issue of the journal Thorax, researchers ...moking. Researchers have looked into the data prov...a firm connection between smoking and incidence of...subjects about 76% of them tested positive for tub...
...d a final guidance titled "Pharmacogenomic Data Su...roducts through the science of pharmacogenomics. P...entify sources of an individual's profile of drug ...le treatment option for this individual. This tech...
...nt component of mammal’s daily life and more so of...tation are known to sleep for over 18 hours. Howev...g in the sea. It has been reported in Nature that ...e wake most of the time in the first month. Their ...
Other Medicine News:Health News:Advent of New, More Effective and Personalized Medicines 2
(Date:7/7/2008)... Expanded HCV Development Presence Includes ANA598...tentially Complementary Mechanisms ..., July 7 /- Anadys Pharmace...t it is resuming clinical,investigation of the Tol...nt of chronic hepatitis C. Based on preclinical ph...
(Date:7/7/2008)... HONG KONG, July 7 /- OrbusNeich to...17th Annual Meeting of the Japanese Society of,Int... Bio-engineered R,stent has better outcomes when c...erico Piscione, M.D., the study,s principal,invest...sity of Naples,s,Division of Cardiology, Departmen...
(Date:7/6/2008)...Results are basis for CTI,s Marketing Authorizatio...er review by the EMEA, SEATTLE, July 7 /PRNewswir...daq: CTIC ; MTA) today announced the publication ...paring OPAXIO(TM) (paclitaxel poliglumex,CT-2103)... of PS 2,(performance status 2) patients with prev...
(Date:7/2/2008)... - Top-line Data Expected in Aug...-- Isolagen(TM), Inc. (Amex:,ILE) announced today ...its,Phase III clinical studies (IT-R-005/006) inve...nt of nasolabial folds, or wrinkles. The last,pers...y follow-up visit,and collation of this data has ...
Breaking Medicine Technology:Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Researchers discover molecular basis of a form of muscular dystrophy 3111 1Researchers discover molecular basis of a form of muscular dystrophy 3111 2LMS CALM 28R 29 receives high customer satisfaction scores in the 2008 KLAS Labor and Delivery report 17995 1LMS CALM 28R 29 receives high customer satisfaction scores in the 2008 KLAS Labor and Delivery report 17995 2LMS CALM 28R 29 receives high customer satisfaction scores in the 2008 KLAS Labor and Delivery report 17995 3BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 1BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 2BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 3BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 4BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 17991 5Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 4969 1Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 4969 2Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 4969 3
...nsive Survey Provides New Benchmark on MRSA,in Hea...ewswire-USNewswire/ -- The,following was released ...ide study of the prevalence of Methicillin-resista...t multi-drug resistant organism, in U.S. h...dy findings significantly exceed previous estimate...
...(June 21, 2007) Nymox Pharmaceutical,Corporation (...s,from the Company’s recently completed stud...PH) will be presented at a series of,upcoming U.S....outh,Central American Urological Association Meeti...resentations will be given by,leading clinical res...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 3
...t immunoassay system built around the many positiv...rtant addition of Logic Driven Incubation (LDI). L...optimal performance with the fastest possible incu...uch as the cardiac biomarkers and HCG to be run in...
For The Detection Of Serum C-Peptide Levels.,Clinical Uses Of C-Peptide Measurement:, Evaluating patients with fasting hypoglycemia , Assisting in the classification of diabetes mellitus , D
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use.
Inquire
Medicine Products: